S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 Tech Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 Tech Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 Tech Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Top 5 Tech Stocks to Buy for 2024 (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
Options trading has suddenly become more reliable. (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The only accurate crypto trading system I know … (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
LON:OKYO

OKYO Pharma (OKYO) Share Price, News & Analysis

→ This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad)
Free OKYO Stock Alerts
Compare
Today's Range
N/A
50-Day Range
1.40
▼
1.40
52-Week Range
N/A
Volume
364,142 shs
Average Volume
431,999 shs
Market Capitalization
£23.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisHeadlinesInsider Trades
OKYO stock logo

About OKYO Pharma Stock (LON:OKYO)

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

OKYO Stock News Headlines

April 17, 2024 | americanbankingnews.com
OKYO Pharma (LON:OKYO) Stock Price Down 24.3%
March 31, 2024 | msn.com
A second Kobayashi Pharma Japan factory inspected over deaths
April 18, 2024 | Priority Gold (Ad)
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
March 31, 2024 | msn.com
Japanese authorities inspect second Kobayashi Pharma factory after deaths
March 30, 2024 | msn.com
Kobayashi factory searched over deaths possibly linked to supplements
March 29, 2024 | msn.com
5 dead and over 100 hospitalized from recalled Japanese health supplements
March 28, 2024 | msn.com
What are 'beni-koji' products linked to Japan deaths?
March 27, 2024 | msn.com
A Japanese supplement pill is recalled after two people died and more than 100 were hospitalized
April 18, 2024 | Priority Gold (Ad)
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.
March 14, 2024 | msn.com
Unicycive rises 4% on $50M private placement
March 3, 2024 | msn.com
People in Japan more worried about smell of others' excrement than their own: survey
February 23, 2024 | msn.com
1 in 4 Japan primary school kids with hay fever's itchy eyes have trouble studying
February 22, 2024 | benzinga.com
OKYO Pharma Stock (NASDAQ:OKYO), Short Interest Report
February 9, 2024 | msn.com
OKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal pain
February 9, 2024 | morningstar.com
OKYO Shares Rise 12% After FDA Clearance for IND Application
January 8, 2024 | markets.businessinsider.com
OKYO Pharma Says Phase 2 Study Of OK-101 Did Not Meet Primary Goal
January 5, 2024 | finance.yahoo.com
OKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024
December 4, 2023 | proactiveinvestors.com
Eyepoint Pharmaceuticals stock soars on wet-AMD trial results
December 4, 2023 | finance.yahoo.com
OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol Visit
November 3, 2023 | msn.com
HC Wainwright & Co. Initiates Coverage of OKYO Pharma Limited - (OKYO) with Buy Recommendation
October 31, 2023 | proactiveinvestors.com
OKYO Pharma raises $5.84m via share issuance
October 31, 2023 | finanznachrichten.de
OKYO Pharma Announces $5.84 Million Cash Raise and Payables Reduction
October 5, 2023 | msn.com
Dry Eye Disease Affects Around 50M Americans, OKYO Pharma's Candidate Shows Safety In Mid-Stage Study
October 5, 2023 | msn.com
OKYO shares retreat 12% after rallying ahead of Phase 2 study update
October 5, 2023 | markets.businessinsider.com
OKYO Pharma Reports Positive Safety Data Profile For OK-101 In Dry Eye Disease
October 5, 2023 | proactiveinvestors.com
OKYO Pharma phase II dry eye trial making encouraging progress
October 5, 2023 | finance.yahoo.com
OKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease ("DED")
See More Headlines
Receive OKYO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:OKYO
CUSIP
N/A
CIK
N/A
Web
www.okyopharma.com
Phone
44 20 7495 2379
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
GBX (0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-6,700,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-397.13%
Return on Assets
-154.72%

Debt

Debt-to-Equity Ratio
1.65
Current Ratio
0.83
Quick Ratio
2.65

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 0.05 per share
Price / Cash Flow
28.00
Book Value
GBX (1) per share
Price / Book
-1.40

Miscellaneous

Outstanding Shares
1,660,000,000
Free Float
N/A
Market Cap
£23.24 million
Optionable
Not Optionable
Beta
-0.06
Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Gary S. Jacob Ph.D. (Age 75)
    CEO & Exec. Director
    Comp: $311k
  • Mr. Michael Paul Beck (Age 65)
    Founder
  • Ms. Keeren Shah (Age 45)
    Chief Financial Officer
  • Dr. Rajkumar Patil Ph.D. (Age 64)
    Chief Scientific Officer

Key Competitors

View All Competitors

OKYO Stock Analysis - Frequently Asked Questions

How do I buy shares of OKYO Pharma?

Shares of OKYO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:OKYO) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Biden’s $374B Giveaway Into This Sector
DTI
A.I. Pioneer Issues Urgent Warning to Americans
TradeSmith
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Man Who Predicted 2008: “This Will be Worse.”
Altimetry